baber/WOPTO huggingface dataset:
Patent PT-1786988-E (PT)
Title: Full wall element of cement stabilised wood wool, method to produce it and building method using it
Inventor: CKERT MATTIAS R
IPC: E04C/
Filed: 2005-08-10
Abstract: Construction elements for walls comprising cement-bound wood wool with chases arranged in the upper edge and along the sides. The construction elements are manufactured of a mixture of wood wool, cement and water, with a weight ratio between wood wool and cement of 1:1.88 and 1:1.92, which is cast in steel moulds. The finished elements have a density of 200-300 kg/m3. A construction system for small buildings comprises the above-described construction elements, which are laterally joined with vertical, concrete columns moulded on site as well as a horizontal ring beam which is cast on site in the upper edge of the element. The elements are placed on the bedding with aid of a guiding rail made by perforated plate and are attached using plaster. The rafters are anchored in a capping piece by aid of angle steel.
Patent PT-1771062-E (PT)
Title: Structure for vegetated wall
Inventor: PELESZEZAK PASCAL
IPC: E01F8/02
Filed: 2005-06-28
Abstract: A light self-supporting vegetated wall includes globally prismatic boxes, designed to be juxtaposed and/or stacked, the adjacent boxes being assembled together. Each box includes latticed or meshed surfaces, lined internally with a web, and filled with a cultivating substrate, such as humus. A network of water pipes and a network of air vents may be incorporated in the thickness of the structure, these networks passing through the parting lines between the boxes. The structure is designed for urban enhancement, as well as for producing noise screens, partition walls, hoardings and the like.
Patent PT-1683817-E (PT)
Title: Anionic copolymers prepared in an inverse emulsion matrix and their use in preparing cellulosic fiber compositions
Inventor: ZHANG FUSHAN
IPC: D21H21/10
Filed: 2002-12-06
Abstract: A papermaking method and a composition which utilize, as a drainage aid, a water-soluble anionic copolymer prepared via a water-in-oil polymerization technique that, absent a crosslinking agent, is characterized by a Huggins' constant (k') determined in 0.01M NaCl greater than 0.75 and a storage modulus (G') for a 1.5 wt.% actives polymer solution at 4.6 Hz greater than 175 Pa.
Patent PT-1844710-E (PT)
Title: Lancet for skin puncture
Inventor: STEG HENNING
IPC: A61B5/15
Filed: 2006-04-13
Abstract: The device has a punch element (12) and a manipulator (13) operably connected to the punch element and a bushing element (14). A lancet (18) is provided with a sharp tip (19) for deliberate entering of a skin. A sleeve element (35) is disposed in an interior (28) of the bushing element in axially slidable relationship. A sleeve projection (38) is slidingly displaced such that it engages a sleeve projection (36) axially from behind. The bushing element displaces a sleeve element axis (16) in the direction of the manipulator.
Patent PT-1891571-E (PT)
Title: Resisting the spread of unwanted code and data
Inventor: SCALES NICHOLAS JOHN
IPC: G06F21/56
Filed: 2006-06-09
Abstract: A method or system of receiving an electronic file containing content data in a predetermined data format, the method comprising the steps of: receiving the electronic file, determining the data format, parsing the content data, to determine whether it conforms to the predetermined data format, and if the content data does conform to the predetermined data format, regenerating the parsed data to create a regenerated electronic file in the data format.
Patent PT-2046947-E (PT)
Title: Method for the production of multipotent stem cells
Inventor: CIFARELLI ROSA ANNA
IPC: C12N5/077
Filed: 2007-07-26
Abstract: The invention relates to a method for the production of multipotent stem cells starting from highly differentiated adult somatic cells of mammals or their precursors comprising the demethylating treatment phase of highly differentiated cells with 5' Aza 2' cytidine and relative kits and uses in the medical field.
Patent PT-545912-E (PT)
Inventor: YANAGISAWA HIROAKI
IPC: A61K/
Filed: 1992-02-21
Abstract: N-Phenylbenzyl imidazole derivs. of formula (I) and their pharmaceutically acceptable salts and esters are new. In (I), R1 = 1-6C alkyl or 3-6C alkenyl; R2 and R3 = H, 1-6C alkyl, 3-6C alkenyl, 3-10C cycloalkyl (opt. polycyclic), aryl(1-6C)alkyl, aryl or aryl fused to 3-10C cycloalkyl; R4 = H, 1-6C alkyl, 1-6C alkanoyl (opt. substd. by one or more halo or 1-6C alkoxy if other than formyl), 3-6C alkenoyl, arylcarbonyl, 1-6C alkoxycarbonyl, tetrahydropyranyl, tetrahydrothiopyranyl, tetrahydrothienyl or tetrahydrofuryl (these 4 opt. substd. by one or more halo or 1-6C alkoxy), SiRaRbRc, 1-6C alkoxymethyl, 1-6C alkoxy(1-6C)alkoxymethyl, halo(1-6C)alkoxymethyl, 1-6C alkyl substd. by at least one aryl, or 1-6C alkanoyl-oxymethoxycarbonyl; Ra, Rb and Rc = 1-6C alkyl or aryl, but not all aryl; R5 = COOH or CONR8R9; R8 and R9 = H, 1-6C alkyl (opt. substd. by at least one (a)) or together are 2-6C alkylene opt. substd. by at least one COOH or alkoxycarbonyl; R6 = H, 1-6C alkyl or alkoxy, or halo; R7 = COOH or tetrazol-5-yl; (a) = aryl, 5-6 membered heterocyclic with 1-4 N, O and/or S, halo, OH, 1-6C alkoxy, COOH, 1-6C alkoxycarbonyl, NH2 or acylamino (acyl = 1-6C alkanoyl or arylcarbonyl); aryl = 6-14C aromatic carbocyclic gp. opt. substd. by at least one of NO2, CN, halo, 6-10C carbocyclic aryl (unsubstd.), 1-6C alkyl or alkoxy, COOH, 1-6C alkoxy-carbonyl, or 1-3C alkylenedioxy or alkylidenedioxy. 23 Cpds. e.g. pivaloyloxymethyl (or (5-methyl-2-oxo -1,3-dioxolen-4-yl)methyl) 4-(1-hydroxy-1-methylethyl) -2-(ethyl, propyl or butyl)-1-(4-(2-tetrazol -5-yl)phenyl)phenyl)methylimidazole -5-carboxylate.
Patent PT-620828-E (PT)
Inventor: STELLA VALENTINO J
IPC: A61K9/18
Filed: 1993-07-26
Abstract: Sulfoalkyl ether cyclodextrin derivatives and their use as solubilizing agents for water insoluble drugs for oral, intranasal, or parenteral administration are disclosed.
Patent PT-727996-E (PT)
Inventor: KYLE LESLIE E
IPC: A61K31/415
Filed: 1994-11-09
Abstract: This application relates to an aqueous formulation of fenbendazole which is stable and efficacious, does not agglomerate upon standing and wherein the fenbendazole remains in suspension after standing for twenty-four hours.
Patent PT-779984-E (PT)
Inventor: MATZINGER P DAVID
IPC: G01N33/52
Filed: 1995-09-08
Abstract: A test strip is provided for having liquid applied thereto and for determining the presence or quantity of an analyte in such liquid. Specifically, the test strip comprises a reaction zone which varies in reflectance as a function of the quantity of analtye present in the applied liquid. The strip is to be inserted into an optical reading apparatus. A standard zone is positioned on the strip so as to lead the reaction zone as the strip is inserted into the reading apparatus. The apparatus may then be provided with optical means for sequentially determining the reflectance value of the standard zone as the strip is being inserted into its fully inserted position in the apparatus and the reflectance value of the reaction zone after the strip has been inserted. The apparatus is further provided with means for calculating the presence and/or quantity of analyte in question as a function of the standard zone reflectance and the reaction zone reflectance.
Patent PT-805817-E (PT)
Inventor: SANTAGELO FRANCESCO
IPC: C07D213/56
Filed: 1996-01-23
Abstract: PCT No. PCT/EP96/00251 Sec. 371 Date Dec. 24, 1996 Sec. 102(e) Date Dec. 24, 1996 PCT Filed Jan. 23, 1996 PCT Pub. No. WO96/22998 PCT Pub. Date Aug. 1, 1996Compounds of formula (I) wherein R, R1, R2, R3, R4, m and n have the meanings reported in the description, processes for their preparation and pharmaceutical compositions which contain them as active ingredients are described. The compounds of formula (I) are endowed with a mixed ACE-inhibitory and NEP-inhibitory activity and are useful in the treatment of cardiovascular diseases.    <IMAGE>
Patent PT-841929-E (PT)
Inventor: DYKE HAZEL JOAN
IPC: A61P19/02
Filed: 1996-08-02
Abstract: 1-Alkyl-substituted-quinolone-3-carboxamides have therapeutic utility via inhibition of Phosphodiesterase IV esterase and/or Tumour Necrosis Factor activity. The compounds of the invention have the general formula (I):    <IMAGE>  (I)  The compounds of the invention encompassed by formula (I) include enantiomers, diastereoisomers and mixtures, including racemic mixtures.
Patent PT-803649-E (PT)
Inventor: SCHIFFER WALTER
IPC: G05D16/06
Filed: 1997-03-25
Abstract: The pressure valve (V) has a valve housing (1,2) enclosing a valve closure plate (8) cooperating with a valve seat (29) and a membrane (5) defining an inlet space (6) and a low pressure space (7), clamped to the valve closure plate via a membrane plate (16) acted on by a coil spring (22). A perpendicular guide rod (18) is formed integral with the valve closure plate and displaced along an axial guide (20) provided by a tube projecting outwards from the rear wall (19) of the low pressure space against which the coil spring acts.
Patent PT-808620-E (PT)
Inventor: SABOLICH JOHN A
IPC: A61F2/78
Filed: 1997-04-23
Abstract: An improved above-the-knee prosthesis with an anatomically configured socket is characterized by one or more contours which correspond to a pre-selected anatomical contour of the upper or lower residual thigh. By exaggerating the depth of the contour in the socket as compared with the corresponding contour in the thigh, the socket grips the residual thigh and maintains the femur in proper alignment. The new channels and contours allow the patient using the socket to have improved rotational support and control over the prosthesis by providing structures which the muscles of the upper and lower residual thigh can "grip." The socket snugly contains the thigh and maintains it, throughout the gait cycle, in a proper anatomical position. This fit increases the comfort of the prosthesis and minimizes gait abnormalities common with other artificial limbs. The increased support helps maintain the physical condition of the residual limb. The extended and new channels allow the muscles of the patient's residual thigh to flex and contract against and around the channels, thereby reducing muscle atrophy. <IMAGE>
Patent PT-951294-E (PT)
Inventor: BEAULIEU ANDRE
IPC: A61K47/38
Filed: 1997-12-12
Abstract: Topical gel and cream formulations containing human plasma fibronectin and other wound healing promoters are used for the healing of cutaneous wounds. The formulations provide slow release and increased contact time of fibronectin and of other wound healing promoters to the wound site leading to the effective absorption of the promoters.
Patent PT-876959-E (PT)
Inventor: TONSEN UWE
IPC: B65B69/00
Filed: 1998-03-18
Abstract: The machine for the preliminary sorting of recycled materials, especially from the household or commercial sectors, has a drum device (1) which can be rotated about a substantially horizontal axis. The device has arms (30) which extend in a radial direction from the axis of rotation, and a mechanism inside the drum can move each arm to and fro in a radial direction so that each arm can be individually extended through a hole in the drum matching its cross sectional shape and then retracted.
Patent PT-1037848-E (PT)
Inventor: MOJZIS KAREL
IPC: B66C23/34
Filed: 1998-12-08
Abstract: The invention relates to a travelling mechanism (2) for an extensively overhanging working device (1) such as a tall building crane, preferably a tower slewing crane, in addition to a travelling mechanism (2) on which such a crane (1) or working device is mounted. The travelling mechanism (2) consists of a chassis (15) with a tandem or twin axle (3, 4) comprising a first (3) and a second (4) axle, whereby the wheels (11a) of both the first (3) and second (4) axle are provided with bogie or axle pivot steering. The bogie or axle pivot steering of the wheels (11a) of the first axle (3) is connected to the bogie or axle pivot steering of the wheels (11b) of the second axle (4) so that the wheels of the first (3) and second axle (4) are geometrically and synchronously steered. Preferably, the wheels of the first (3) and second (4) axle are arranged in a supporting area of the working device (1), as in a crane (1). The travelling mechanism (2) also comprises a traction device (28) which is separate from the chassis (15) and which is joined to a tractor vehicle. Said tractor device (28) is attached to the working device (1) and thus connected to the travelling mechanism (2), whereby the working device, in its preferred embodiment as a crane, functions as part of the chassis (15) during transport and manoeuvring.
Patent PT-1048226-E (PT)
Inventor: KRATKY ZDENEK
IPC: A23L33/00
Filed: 1999-04-29
Abstract: An infant formula which contains a lipid source, a carbohydrate source, and a protein source. The protein source contains the free amino acids arginine, tyrosine, and histidine and a hydrolysed sweet whey fraction from which caseino-glyco-macropeptide has been removed. The infant formula is low in threonine and high intrypotophan. The infant formula may be a pre-term formula or a full-term hypoallergenic formula.
Patent PT-992477-E (PT)
Inventor: THERRE JORG
IPC: C07C47/21
Filed: 1999-09-17
Abstract: Preparation of citral (I) comprises thermal decomposition of 3-methyl-2-buten-1-al-diprenylacetal and rearrangement of obtained intermediates cis/trans-prenyl-(methyl-butadienyl)-ether (IV) and 2,4,4-trimethyl-3-formyl-1,5-hexadiene (V). (IV) and (V) are continuously distilled off and converted into (I) before or after removal of by-product prenol. Preparation of 3,7-dimethyl-2,6-octadien-1-al (citral) of formula (I) comprises: (1) thermal decomposition of 3-methyl-2-buten-1-al-diprenylacetal of formula (II) optionally in the presence of an acid catalyst to split off 3-methyl-buten-1-ol (prenol) of formula (III) and form cis/trans-prenyl-(methyl-butadienyl)-ether of formula (IV); (2) Claisen rearrangement of (IV) to give 2,4,4-trimethyl-3-formyl-1,5-hexadiene of formula (V); and (3) Cope rearrangement of (V) to form (I). The transitionally formed (IV) and (V) and the desired citral as well as the prenol (III) are continuously distilled out of the reaction mixture and (IV) and (V), before or after distillative separation of (III) and optional by-products, are subjected to rearrangement to form (I) at 100-200 degrees C.
Patent PT-1006128-E (PT)
Inventor: FOUACHE CATHERINE
IPC: A23L33/20
Filed: 1999-12-03
Abstract: Branched maltodextrins (I) having 22-35% of 1-6 glucoside linkages, a reducing sugar content of less than 20%, a polymolecularity index (Mw/Mn) of less than 5 and a number-average molecular weight (Mn) of up to 4500 are new. Independent claims are also included for: (1) an acariogenic composition comprising (I) and at least one polyol; (2) a process for preparing (I), comprising: (a) preparing an acidified starch with a moisture content below 5%; (b) heating the starch in a continuous thin-film reactor at 120-300 degrees C; (c) recovering, purifying and preferably concentrating the resulting branched starch derivatives; and (d) fractionating the starch derivatives according to Mn.
Patent PT-995364-E (PT)
Inventor: MARCOLIN GIUSEPPE
IPC: A43B7/26
Filed: 1999-10-21
Abstract: The present invention relates to a footwear anatomical arch support characterised by special comfort thanks to the presence of specific suitable modelling on the upper surface. <IMAGE>
Patent SG-45391-G (SG)
Title: Tri-level sandcastle pulse decoder
IPC: H04N9/44
Filed: 1991-06-15
Abstract: Trilevel sandcastle pulse decoder includes a trio of voltage comparators for comparing incoming sandcastle pulses with reference potentials of respectively different levels. One of the voltage comparators, which is subject to change in operating state in response to appearance of a given level of the sandcastle pulse, is precluded from operating state change in response to the appearance of the next higher level of the sandcastle pulse by control circuitry responsive to the output of a second of the voltage comparators. One of the decoder outputs is developed by logic circuitry responsive to outputs of two of the comparators.
Patent SG-81884-G (SG)
Title: Three phase power factor controller
IPC: G05F1/70
Filed: 1984-11-14
Abstract: A power consumption reducing control circuit for a three phase induction motor (10), wherein power factors (P1, P2, P3) for the three phases (A, B, C) are separately determined and summed to provide a composite control signal, which is suitably conditioned (64, 66) and then employed to control the duty cycle of each phase of input power to the motor (10) through the appropriately timed gating of thyristors or Triacs (12, 14, 16).
Patent IE-890395-L (IE)
Title: Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity
IPC: C07D493/10
Filed: 1989-02-07
Abstract: An acidic polycyclic ether antibiotic, having structure established by X-ray crystallography, is formed by fermentation of a novel microorganism, Actinomadura sp. ATCC 53708. This novel antibiotic is useful as an anticoccidial in chickens, in the prevention or treatment of swine dysentery, and as a growth promotant in cattle and swine.
Patent IE-810670-L (IE)
Title: Immobilized lactase
IPC: C12N11/08
Filed: 1981-03-25
Abstract: PURPOSE:To obtain a water-insoluble immobilized lactase having high polysaccharide-decomposing capability and high stability, by immobilizing lactase originated from Aspergillus oryzae to a macroporous phenol-formaldehyde-type anion exchange resin. CONSTITUTION:Lactase originated from Aspergillus oryzae is adsorbed in an aqueous solution of pH4.0-6.5 to a carrier consisting of a macroporous phenol-formaldehyde-type anion exchange resin having a specific surface area of >=5m<2>/g, a micropore volume of >=0.2cc/g (100-2,000Angstrom in pore diameter), and an anion exchange capacity (based on amino group, substituted amino group, or their mixture) of >=1meg/g. The adsorbed lactase is immobilized by treating with an aqueous solution of glutaraldehyde at pH3.5-7.0. After the immobilization reaction, the immobilized lactase is thoroughly washed with a high-salt-content buffer solution and water to remove completely the lactase molecules which are easily releasable owing to in complete bonding.
[JP56140890A]
Patent IE-39225-L (IE)
Title: Penicillin derivatives
IPC: A23K20/195
Filed: 1974-04-18
Abstract: A compound of the formula:
[US3923789A]
Patent IE-830845-L (IE)
Title: Process for polymerising conjugate diolefins and means¹suitable for this purpose
IPC: C08F4/60
Filed: 1983-04-14
Abstract: A new process is described for polymerising and copolymerising conjugate diolefins, characterised by using a catalytic system formed from at least one metal pertaining to Group III B of the Periodic System, at least one non-halogenated aluminium alkyl, at least one organic halogen derivative or a halide of an element also able to exist in a lower valency state, and at least one compound containing one or more salifiable hydroxyl groups, i.e. of acid or neutral type. The new process allows the preparation, both in the absence and in the presence of inert diluents, of conjugate diolefin polymers of linear structure which are essentially entirely 1,4-cis. The method for preparing the new catalytic system is also described.
[US4436884A]
Patent FI-851350-L (FI)
Inventor: BJOERK ANDERS KARL KONRAD
IPC: C07D405/06
Filed: 1985-04-03
Abstract: 1-piparazinecarboxamide derivatives are described which have the formula (I) 
<CHEM>
 wherein R1 is a member selected from hydrogen, halogen or trifluoromethyl;
 wherein X is selected from:
 > CO (Ia)
 > CHOH (Ib) > CHOR8 (Ib min ) > CHOCOR8 (Ib sec )
 > CH2 (Ic)
 > C = CR6R7 (Id)
 > CH - CHR6R7 (Ie) 
<CHEM>
 wherein R2 and R3 are the same or different and selected from hydrogen or lower alkyl;
 wherein Z ist either oxygen or sulfur;
 wherein Y is -NR4R5, where R4 and R5 are the same or different and selected from hydrogen, alkyl, alkenyl, cycloalkyl, aryl, aryl-(lower alkyl), or R4 and R5 may together with the N-atom form a 5- or 6- or 7-membered satin red ring, where one of the carbon atoms may be exchanged for O, NR8 or NCOR8;
 wherein R6 and R7 are the same or different and selected from hydrogen or lower alkyl;
 wherein R8 is lower alkyl or lower alkenyl;
 with the proviso that when X is > CO, then R4 is hydrogen and R5 is different from hydrogen. 
<??>Pharmaceutical compositions containing said 1-piperazinecarboxamide derivates are also described. 
<??>The derivatives are useful in treating mental disorders and/or aggression in man and in treating aggression in animals and for calming animals. 
<??>Different processes for preparing the derivatives are also described.
Patent IE-791595-L (IE)
Title: Coupling a branchline to a conduit carrying a pressure¹medium
IPC: F16L41/18
Filed: 1979-08-20
Abstract: A device for detachably coupling the orifice of a branchline to a line carrying a pressure medium and having a plurality of discharge valves spaced apart from each other in the line wall, the coupling being carried out by means of a coupling device which is movable over the length of the line and contains the orifice and opens one of the discharge valves. The discharge valves are mounted in the line with magnetically actuating opening members and the coupling device is provided with a coupling element guided thereon and is provided with an automatically sealing coupling member in the coupling position with the discharge valve at the pressure side for an automatic alignment with the orifice, and an actuator which magnetically cooperates with the opening member and the coupling member.
[US4296774A]
Patent IE-861599-L (IE)
Title: Ergolines.
IPC: C07D457/02
Filed: 1986-06-17
Abstract: Ergoline derivatives of the formula Iwherein R<sub>1</sub>=H, CH<sub>3</sub>; R<sub>2</sub>=H, halogen, CH<sub>3</sub>, CN, C<sub>1</sub>-C<sub>4</sub> alkylthio or phenylthio; R<sub>3</sub>=C<sub>1</sub>-C<sub>4</sub> hydrocarbon; R<sub>4</sub>=H, OCH<sub>3</sub>; R<sub>5</sub>=H and R<sub>6</sub>=-CH=CH-CONHR<sub>7</sub> or R<sub>5</sub> + R<sub>6=</sub> =CH-CONHR<sub>7</sub>; R<sub>7=</sub> 2-thiazolyl, 3-pyridazinyl, 1,3,4-thiadiazol-2-yl or 4-pyrimidinyl group optionally substituted, and pharmaceutically acceptable salts thereof, display activity on the Central Nervous System and are useful as antiprolactinic agents. Their preparation, pharmaceutical compositions containing them, and their use in the preparation of a medicament for the treatment of Parkinson's disease are also described.
Patent IE-801711-L (IE)
Title: Dispensing container
IPC: A47K10/20
Filed: 1980-08-13
Abstract: A dispensing device for towels and like articles comprises a container having a removal closure with a slitted opening and a cap integral therewith for closing the slitted opening, and includes a threading protrusion integral with the cap for receipt through the slitted opening whereby a towel may be engaged therewith and drawn from the container through the slitted opening to initiate dispensing of towels through the slitted opening.
[US4337876A]